MYUNGMOON Pharm co.,Ltd (KRX: 017180)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,050.00
-80.00 (-3.76%)
Oct 11, 2024, 3:30 PM KST
-5.53%
Market Cap 68.23B
Revenue (ttm) 176.37B
Net Income (ttm) -7.72B
Shares Out 33.53M
EPS (ttm) -231.81
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 128,683
Open 2,130.00
Previous Close 2,130.00
Day's Range 2,050.00 - 2,130.00
52-Week Range 1,888.00 - 2,970.00
Beta 0.18
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About MYUNGMOON Pharm co.,Ltd

MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics,... [Read more]

Sector Healthcare
Founded 1983
Employees 281
Stock Exchange Korea Stock Exchange
Ticker Symbol 017180
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.